Health In Tech Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Net Income	1.44	0.67	3.96	0.08
Other Amortization	0.63	1.04	0.34	-
Stock-Based Compensation	1.96	0.47	-	0.57
Other Operating Activities	2.25	-0.16	0.12	-0.31
Change in Accounts Receivable	0.06	0.59	-1.28	-0.78
Change in Accounts Payable	2.26	-0.85	2.15	0.45
Change in Income Taxes	-0.38	-0.25	0.33	0.12
Change in Other Net Operating Assets	-6.06	0.67	-1.87	0
Operating Cash Flow	2.15	2.18	1.53	0.78
Operating Cash Flow Growth	-6.53%	42.34%	95.32%	-
Sale (Purchase) of Intangibles	-2.96	-0.9	-1.14	-1.22
Other Investing Activities	0.06	0.06	-0.8	-
Investing Cash Flow	-2.9	-0.84	-1.94	-1.22
Short-Term Debt Issued	-	-	1.65	-
Total Debt Issued	-	-	1.65	-
Short-Term Debt Repaid	-	-2.15	-	-
Long-Term Debt Repaid	-	-	-	-0.07
Total Debt Repaid	-	-2.15	-	-0.07
Net Debt Issued (Repaid)	-	-2.15	1.65	-0.07
Issuance of Common Stock	8.21	8.21	-	-
Common Dividends Paid	-	-	-	-0.05
Other Financing Activities	-1.19	-1.98	-0.31	-
Financing Cash Flow	7.03	4.09	1.34	1.88
Net Cash Flow	6.28	5.43	0.93	1.44
Cash Interest Paid	-	-	-	0
Levered Free Cash Flow	-0.32	1.41	-0.09	-
Unlevered Free Cash Flow	-0.32	1.23	-0.09	-
Change in Working Capital	-4.12	0.16	-0.67	-0.2

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q